These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 18196604)

  • 1. An examination of acute changes in serotonergic neurotransmission using the loudness dependence measure of auditory cortex evoked activity: effects of citalopram, escitalopram and sertraline.
    Guille V; Croft RJ; O'Neill BV; Illic S; Phan KL; Nathan PJ
    Hum Psychopharmacol; 2008 Apr; 23(3):231-41. PubMed ID: 18196604
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chronic modulation of serotonergic neurotransmission with sertraline attenuates the loudness dependence of the auditory evoked potential in healthy participants.
    Simmons JG; Nathan PJ; Berger G; Allen NB
    Psychopharmacology (Berl); 2011 Sep; 217(1):101-10. PubMed ID: 21465243
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Direct evidence that acutely enhancing serotonin with the selective serotonin reuptake inhibitor citalopram modulates the loudness dependence of the auditory evoked potential (LDAEP) marker of central serotonin function.
    Nathan PJ; Segrave R; Phan KL; O'Neill B; Croft RJ
    Hum Psychopharmacol; 2006 Jan; 21(1):47-52. PubMed ID: 16317803
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Loudness dependence of auditory evoked potentials as indicator of central serotonergic neurotransmission: simultaneous electrophysiological recordings and in vivo microdialysis in the rat primary auditory cortex.
    Wutzler A; Winter C; Kitzrow W; Uhl I; Wolf RJ; Heinz A; Juckel G
    Neuropsychopharmacology; 2008 Dec; 33(13):3176-81. PubMed ID: 18463629
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The loudness dependence auditory evoked potential is insensitive to acute changes in serotonergic and noradrenergic neurotransmission.
    Oliva J; Leung S; Croft RJ; O'Neill BV; O'Kane J; Stout J; Phan KL; Nathan PJ
    Hum Psychopharmacol; 2010 Jul; 25(5):423-7. PubMed ID: 20589921
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is the loudness dependence of auditory evoked potentials modulated by the selective serotonin reuptake inhibitor citalopram in healthy subjects?
    Uhl I; Gorynia I; Gallinat J; Mulert C; Wutzler A; Heinz A; Juckel G
    Hum Psychopharmacol; 2006 Oct; 21(7):463-71. PubMed ID: 17029304
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serotonergic dysfunction in schizophrenia assessed by the loudness dependence measure of primary auditory cortex evoked activity.
    Juckel G; Gallinat J; Riedel M; Sokullu S; Schulz C; Möller HJ; Müller N; Hegerl U
    Schizophr Res; 2003 Nov; 64(2-3):115-24. PubMed ID: 14613676
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The loudness dependence of the auditory evoked potential (LDAEP) as a predictor of the response to escitalopram in patients with generalized anxiety disorder.
    Park YM; Kim DW; Kim S; Im CH; Lee SH
    Psychopharmacology (Berl); 2011 Feb; 213(2-3):625-32. PubMed ID: 21057773
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pindolol does not augment central serotonin function increases to citalopram in humans: an auditory evoked potential investigation.
    Segrave R; Croft RJ; Illic S; Phan KL; Nathan PJ
    Pharmacol Biochem Behav; 2006 Sep; 85(1):82-90. PubMed ID: 16904172
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between the loudness dependence of auditory evoked potential, serotonergic neurotransmission and treatment outcome in patients with depression.
    Ip CT; Ganz M; Ozenne B; Olbrich S; Beliveau V; Dam VH; Köhler-Forsberg K; Jørgensen MB; Frøkjær VG; Knudsen GM
    Eur Neuropsychopharmacol; 2023 May; 70():32-44. PubMed ID: 36863106
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prediction of long-term treatment response to selective serotonin reuptake inhibitors (SSRIs) using scalp and source loudness dependence of auditory evoked potentials (LDAEP) analysis in patients with major depressive disorder.
    Lee BH; Park YM; Lee SH; Shim M
    Int J Mol Sci; 2015 Mar; 16(3):6251-65. PubMed ID: 25794285
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of selective and combined serotonin and dopamine depletion on the loudness dependence of the auditory evoked potential (LDAEP) in humans.
    O'Neill BV; Guille V; Croft RJ; Leung S; Scholes KE; Phan KL; Nathan PJ
    Hum Psychopharmacol; 2008 Jun; 23(4):301-12. PubMed ID: 18213738
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential prediction of first clinical response to serotonergic and noradrenergic antidepressants using the loudness dependence of auditory evoked potentials in patients with major depressive disorder.
    Juckel G; Pogarell O; Augustin H; Mulert C; Müller-Siecheneder F; Frodl T; Mavrogiorgou P; Hegerl U
    J Clin Psychiatry; 2007 Aug; 68(8):1206-12. PubMed ID: 17854244
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship between SSRI-induced sexual dysfunction and central serotonergic activity based on the loudness dependence of auditory evoked potentials.
    Park YM
    Psychopharmacology (Berl); 2014 Feb; 231(3):551-5. PubMed ID: 24005532
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The loudness dependence of the auditory evoked potential (LDAEP) as an in vivo biomarker of central serotonergic function in humans: rationale, evaluation and review of findings.
    O'Neill BV; Croft RJ; Nathan PJ
    Hum Psychopharmacol; 2008 Jul; 23(5):355-70. PubMed ID: 18421800
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identifying psychiatric patients with serotonergic dysfunctions by event-related potentials.
    Hegerl U; Juckel G
    World J Biol Psychiatry; 2000 Apr; 1(2):112-8. PubMed ID: 12607207
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preserved Serotonergic Activity in Early-Onset Parkinson's Disease.
    Park HK; Lee JJ; Park YM
    Can J Neurol Sci; 2020 May; 47(3):344-349. PubMed ID: 31685057
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Event-related potentials. Do they reflect central serotonergic neurotransmission and do they predict clinical response to serotonin agonists?
    Hegerl U; Gallinat J; Juckel G
    J Affect Disord; 2001 Jan; 62(1-2):93-100. PubMed ID: 11172876
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Augmenting serotonin neurotransmission with citalopram modulates emotional expression decoding but not structural encoding of moderate intensity sad facial emotional stimuli: an event-related potential (ERP) investigation.
    Labuschagne I; Croft RJ; Phan KL; Nathan PJ
    J Psychopharmacol; 2010 Aug; 24(8):1153-64. PubMed ID: 18832432
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison between the analysis of the loudness dependency of the auditory N1/P2 component with LORETA and dipole source analysis in the prediction of treatment response to the selective serotonin reuptake inhibitor citalopram in major depression.
    Mulert C; Juckel G; Augustin H; Hegerl U
    Clin Neurophysiol; 2002 Oct; 113(10):1566-72. PubMed ID: 12350432
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.